Ms Christine Zheng, chairman of Fangyuan Capital, was invited to attend the 2023 Global Biotech Expo

The China Everbright International Suzhou Healthcare Investment Summit concluded on 28^th June 2023 in Suzhou. It attracted experts in the Chinese medical industries and established investment institutions to discuss the future of the Chinese healthcare industry. Ms Zheng shared her views about the industry during the “How to perceive the risks and opportunities of healthcare industry investment” panel.

Home

Leadership

News

Contact us

Career

Copyright © Prudence Financial Group. All Rights Reserved

Disclaimer

DISCLAIMER

This website contains information about Prudence Financial Group and its affiliates (” Prudence “) and the products and/or funds offered by Prudence (” Prudence Funds “). This website is not directed to any person in any jurisdiction where the publication or availability of the Prudence website is prohibited. Persons in respect of whom such prohibitions apply must not access the Prudence website.

The information provided on this website should not be considered as a solicitation, invitation, recommendation or offer to purchase a product offered by Prudence or any Prudence Funds or as the basis to deal in any of the investments mentioned herein, by anyone in any jurisdiction in which such offer or solicitation would be unlawful or in which the person making such offer or solicitation is not qualified to do so or to anyone to whom it is unlawful to make such offer or solicitation. Those who access this website do so on their own initiative and are therefore responsible for observing all applicable laws and regulations of their relevant jurisdictions before proceeding to access the information contained herein.

Investment involves risks. Past performance is not a reliable indicator of its future performance. Prudence does not guarantee the performance of any of each Prudence Funds, the return of an investor’s capital nor any specific rate of return. Value of investments can go down as well as up.

Prudence has taken reasonable care to ensure that the information contained on this website is accurate and up to date at the time of publishing, the information on this website is provided “as is” without any warranty of any kind and may no longer be true or complete when viewed by you. Prudence cannot guarantee that content will be accurate, complete and current at all times. To the extent that any information on this website relates to a third party, such information has been provided by that third party and is the sole responsibility of such third party and Prudence accepts no liability for such information. All content on the website is subject to modification from time to time without notice. You must conduct your own due diligence and investigations rather than relying on any of the information in this website .Any person who acts upon the information contained on this website does so entirely at his own risk. Prudence shall not be liable for any losses or damages relating to adequacy, accuracy or completeness of any information on this website or the use of such information.

This website links to the password protected areas and the information contained in or through those areas are provided only to Prudence’s clients. Nothing on this website constitutes an offer of securities for sale to any person in the United States. Shares of Prudence Funds may not be offered, sold or delivered directly or indirectly in the United States or to or for the account or benefit of any “US Person” except pursuant to an exemption from, or in a transaction not subject to, the registration requirements of the 1933 Act and any applicable state laws.

Prudence cannot extend it services at retail level. Prudence Funds which are managed in Hong Kong are not currently available to persons residing in Hong Kong other than professional investors. The term “professional investor” is as defined in the Securities and Futures Ordinance and its subsidiary legislation in Hong Kong. Prudence Funds which are managed in Singapore are not currently available to persons residing in Singapore other than accredited investors or institutional investors. The terms “accredited investor” and “institutional investor” are as defined under Section 4(A) of the Securities and Futures Act in Singapore.

Complaints from clients concerning Prudence or Prudence Funds should be directed to ir@prudenceinv.com (for Prudence Investment Management (Hong Kong) Limited) or fycapital@prudenceinv.com (for Fangyuan Capital (Hong Kong) Limited). Prudence will handle or channel to the relevant party any complaints from clients and will revert to the clients accordingly. An acknowledgement and a final response of the complaint shall be issued by Prudence within 7 days and 28 days of the day of receipt respectively.

All copyrights reserved and its contents including all information, graphics, code, text and design in this website are owned by Prudence and should not be reproduced or distributed without its permission. These Terms are governed exclusively by the laws of Hong Kong Special Administrative Region and constitute the entire agreement between you and Prudence in relation to the use of this website.

Prudence Asset Management Pte. Ltd. is regulated by Monetary Authority of Singapore. Prudence Investment Management (Hong Kong) Limited is regulated by the Securities and Futures Commission of Hong Kong (“ SFC ”). This website has not been reviewed by the Securities and Futures Commission of Hong Kong and Monetary Authority of Singapore, and may contain information of non-SFC and non-MAS authorized funds issued by Prudence Financial Group.

If you are in any doubt about any of the information contained in this website including the terms of use, please consult independent professional advice first.